7,658 results on '"Adenomatous Polyps"'
Search Results
2. Testing ONC201 to Prevent Colorectal Cancer
- Published
- 2024
3. Early Detection of Advanced Adenomas and Colorectal Cancer (AACRC)
- Published
- 2024
4. Predicting Adenomatous Polyps in the Colon Using Images of a Human Tongue
- Published
- 2024
5. Performance and Safety of MiWEndo-assisted Colonoscopy (MiWEndo II)
- Published
- 2024
6. Liquid Biopsy Based Multiomics Study for Colorectal Cancer Early Screening (COLO-LIMULOID)
- Author
-
Sheng Dai, Principal Investigator, head of medical affairs
- Published
- 2024
7. Multi-omics Study for Early Detection of Colorectal Cancer (MOED-CRC)
- Author
-
New Horizon Health Technology Co., Ltd and Ding Ke-Feng, Chief physician
- Published
- 2024
8. Exploratory Study of a Novel Based rbcDNA Liquid Biopsy Technique for Colorectal Cancer Early Detection
- Author
-
Timing Biotech Co.Ltd. and Jun Li, Chief
- Published
- 2024
9. Current sessile serrated lesion incidence: implications for future clinical practice.
- Author
-
Bone, Emma, Kumar, Shiristi, Richards, Simon, McCombie, Andrew, Chalmers‐Watson, Teresa, Glyn, Tamara, and Eglinton, Tim
- Subjects
- *
ADENOMATOUS polyps , *COLON cancer , *COLORECTAL cancer , *COMPUTED tomography , *EARLY detection of cancer , *POLYPECTOMY - Abstract
Background Methods Results Conclusion Sessile serrated lesions (SSL) account for up to 30% of colorectal carcinoma pathogenesis. With multiple classification changes and improvements in colonoscopy equipment and technique, historical reporting may have underestimated the true incidence of SSLs. This study aimed to determine the incidence of SSLs in patients undergoing colonoscopic investigation in Canterbury, New Zealand over a 1‐year period and describe their clinical and pathological characteristics.Electronic records were searched to identify all lower endoscopy procedures with polypectomy performed from 1 January 2022 to 1 December 2022 (inclusive). Patients' electronic records were used to collect histological classification, location and size of each polyp removed during their procedure. The primary outcome was the number of procedures that had one or more SSL, adenoma or hyperplastic polyp identified. Secondary outcomes included histological classification, location and size of each polyp removed.There were 4346 procedures completed during the study period. Of these, 64.1% (2786) had a polypectomy and 18.6% (808) had at least one SSL excised. Individual polyp analysis was completed on 9166 polyps and found that 24.0% of polyps removed were SSLs and they were found predominately in the right colon (65.1% right colon, 32.6% left colon, 2.3% rectum). SSLs were typically <10 mm (84.8%).This study found a higher incidence of SSLs compared to previous research. These results raise questions regarding whether SLL rates have been historically underestimated, whether SSL detection rate should be included as a key performance indicator and raises further concerns regarding the use of computed tomography colonography as a screening tool. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
10. Utility of Simple and Non-Invasive Strategies Alternative to Inferior Petrosal Sinus Sampling and Peripheral CRH Stimulation in Differential Diagnosis of ACTH-Dependent Cushing Syndrome.
- Author
-
Attri, Bhawna, Goyal, Alpesh, Kalaivani, Mani, Kandasamy, Devasenathipathy, Gupta, Yashdeep, Agarwal, Shipra, Shamim, Shamim A., Damle, Nishikant, Sharma, Mehar Chand, Jyotsna, Viveka P., Suri, Ashish, and Tandon, Nikhil
- Subjects
- *
CUSHING'S syndrome , *DIFFERENTIAL diagnosis , *ADRENOCORTICOTROPIC hormone , *HYPOKALEMIA , *HYDROCORTISONE , *ADENOMATOUS polyps - Abstract
We aimed to evaluate the utility of simple, cost-effective, and non-invasive strategies alternative to BIPSS and peripheral CRH stimulation in differential diagnosis of ACTH-dependent CS. First, we performed ROC analysis to evaluate the performance of various tests for differential diagnosis of ACTH-dependent CS in our cohort (CD, n=76 and EAS, n=23) and derived their optimal cut-offs. Subsequently, combining various demographic (gender), clinical (hypokalemia), biochemical (plasma ACTH, HDDST, peripheral CRH stimulation) and imaging (MRI pituitary) parameters, we derived non-invasive models with 100% PPV for CD. Patients with pituitary macroadenoma (n=14) were excluded from the analysis involving non-invasive models. Relative percent ACTH (AUC: 0.933) and cortisol (AUC: 0.975) increase on peripheral CRH stimulation demonstrated excellent accuracy in discriminating CD from EAS. Best cut-offs for CD were plasma ACTH<97.3 pg/ml, HDDST≥57% cortisol suppression, CRH stimulation≥77% ACTH increase and≥11% cortisol increase. We derived six models that provided 100% PPV for CD and precluded the need for BIPPS in 35/85 (41.2%) patients with ACTH-dependent CS and no macroadenoma (in whom BIPSS would have otherwise been recommended). The first three models included basic parameters and avoided both peripheral CRH stimulation and BIPSS in 19 (22.4%) patients, while the next three models included peripheral CRH stimulation and avoided BIPSS in another 16 (18.8%) patients. Using simple and non-invasive alternative strategies, BIPSS can be avoided in 41% and peripheral CRH stimulation in 22% of patients with ACTH-dependent CS and no macroadenoma; such patients can be directly referred for a pituitary surgery. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
11. Glandular Crowdings in Endometrial Polyps: Clinical Follow-Up and Possible Worrisome Features.
- Author
-
Koç, Nermin and Ertürk Coşkun, Ayşe Deniz
- Subjects
- *
PRECANCEROUS conditions , *POLYPS , *MACROPHAGES , *BIOPSY , *GLANDS , *ADENOMATOUS polyps , *ENDOMETRIUM - Abstract
Introduction: Interpretation of changes and premalignant lesions in endometrial polyps can be challenging. We evaluated the clinical course of patients with focal gland crowdings in endometrial polyps via repeat biopsies and searched for possible morphological findings in the initial biopsy that may foresee a premalignant course. Methods: Specimens diagnosed as endometrial polyp and focal gland crowding in patients who had a repeat biopsy in a 1-year period were reexamined. Morphological findings in the initial biopsies were recorded. The group whose repeat biopsies were "premalignant or malignant" (Group 1), and the group with "benign" repeat biopsies (Group 2) were compared. Results: "Endometrial polyp and gland crowdings" was diagnosed in 115 specimens of which 38 patients had repeat biopsies. Among these 8 (21%) were diagnosed as "endometrial intraepithelial neoplasia (EIN)" (Group 1) and 30 (79%) as "benign" (Group 2). Morphological features in the initial biopsies were evaluated; PAX2 loss was 6 of 8 (75%) for Group 1 and 7 of 30 (23%) for Group 2 (P =.020), and altered epithelial cytological features were present in 5 of 8 (62%) versus 4 of 30 (13%) (P =.015), both significantly higher in Group 1. Dark intraluminal secretion, intraluminal histiocytes, intraglandular epithelial proliferation, and mean diameter of crowded gland areas were not statistically different between the 2 groups. Conclusion: "Focal gland crowdings" in endometrial polyps do carry a risk of EIN in subsequent biopsies. We suggest that the loss/decrease of PAX2 and altered epithelial cytological features in these areas in the initial biopsy are indicative of a premalignant course. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
12. The role of BMI, serum lipid profile molecules and their derivative indexes in colorectal polyps.
- Author
-
Huang, Chunyu, Liang, Weipeng, and Sun, Yuying
- Subjects
HDL cholesterol ,ADENOMATOUS polyps ,BODY mass index ,RESEARCH funding ,RECEIVER operating characteristic curves ,HYPERLIPIDEMIA ,LIPIDS ,MULTIPLE regression analysis ,RETROSPECTIVE studies ,COLON polyps ,CHOLESTEROL ,APOLIPOPROTEINS ,TRIGLYCERIDES ,COLONOSCOPY ,DISEASE risk factors ,DISEASE complications - Abstract
To investigate the role of body mass index (BMI), serum lipid profile molecules and their derivative indexes in colorectal polyps. A total of 352 individuals who underwent colonoscopy at our center were included in this retrospective analysis. Of these, 247 patients without evident abnormalities (control group), while 105 patients diagnosed with colorectal polyps (patient group). Serum lipid profile molecules and their derivative indexes were then compared between the two groups. The patient group exhibited significantly higher levels of total cholesterol (TC) and apolipoprotein B (ApoB) compared to the control group (p<0.05). In males, the patient group displayed elevated levels of ApoB and ApoB/ApoA1 ratio compared to the control group (p<0.05). Additionally, the triglycerides (TG) and TG/high-density lipoprotein-cholesterol (HDL-C) ratios were significantly higher in the multiple polyps group than in the single polyp group (p<0.05). Furthermore, the HDL-C and HDL-C/ApoA1 ratio levels were higher in the adenomatous polyp group when compared to the non-adenomatous polyp group (p<0.05). Multiple logistic regression analysis indicated that total cholesterol (TC), TG, low-density lipoprotein-cholesterol (LDL-C), TC/HDL-C ratio, TG/HDL-C ratio and LDL-C/HDL-C ratio were risk factors for the occurrence of colorectal polyps (p<0.05). ROC curve analyses revealed that TC, ApoB, and ApoB/ApoA1 ratio were associated with colorectal polyps. No significant difference in BMI between the two groups (p>0.05). The incidence and progression of colorectal polyps are linked to serum lipid molecules and their derivative indexes. Dyslipidemia may increase the risk of colorectal polyps, potentially leading to colorectal cancer (CRC). [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
13. Kidney Function in Patients With Adrenal Adenomas: A Single-Center Retrospective Cohort Study.
- Author
-
Rahimi, Leili, Kittithaworn, Annop, Garcia, Raul Gregg, Saini, Jasmine, Dogra, Prerna, Atkinson, Elizabeth J, Achenbach, Sara J, Kattah, Andrea, and Bancos, Irina
- Subjects
ANGIOTENSIN-receptor blockers ,ACE inhibitors ,DISEASE risk factors ,GLOMERULAR filtration rate ,CHRONIC kidney failure ,ADENOMATOUS polyps - Abstract
Context Patients with nonfunctioning adrenal adenomas (NFA) and mild autonomous cortisol secretion (MACS) demonstrate an increased risk of chronic kidney disease (CKD); however, factors associated with CKD are unknown. Objective We aimed to identify the factors associated with CKD and assess the effect of adrenalectomy on kidney function in patients with NFA or MACS. Methods A single-center cohort study of patients with NFA and MACS, 1999 to 2020, was conducted. MACS was diagnosed based on post dexamethasone suppression test (DST) cortisol greater than or equal to 1.8 mcg/dL. Age, sex, dysglycemia, hypertension, therapy with statin, angiotensin-converting enzyme inhibitor, or angiotensin II receptor blocker were included in the multivariable analysis. Outcomes included estimated glomerular filtration rate (eGFR) at the time of diagnosis with MACS or NFA and postadrenalectomy delta eGFR. Results Of 972 patients, 429 (44%) had MACS and 543 (56%) had NFA. At the time of diagnosis, patients with MACS had lower eGFR (median 79.6 vs 83.8 mL/min/1.73 m
2 ; P <.001) than patients with NFA. In a multivariable analysis, factors associated with lower eGFR were older age, hypertension, and higher DST. In 204 patients (MACS: 155, 76% and NFA: 49, 24%) treated with adrenalectomy, postadrenalectomy eGFR improved in both groups starting at 18 months up to 3.5 years of follow-up. Factors associated with increased eGFR were younger age, lower preadrenalectomy eGFR, and longer follow-up period. Conclusion DST cortisol is an independent risk factor for lower eGFR in patients with adrenal adenomas. Patients with both MACS and NFA demonstrate an increase in eGFR post adrenalectomy, especially younger patients with lower eGFR pre adrenalectomy. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
14. Astragaloside IV Ameliorates Colonic Adenomatous Polyps Development by Orchestrating Gut <italic>Bifidobacterium</italic> and Serum Metabolome.
- Author
-
Wen, Lu-Ping, Gao, Shao-Wei, Chen, Hua-Xian, Liu, Qi, Xiao, Guo-Zhong, Lin, Hong-Cheng, and He, Qiu-Lan
- Subjects
- *
ADENOMATOUS polyps , *HIGH-fat diet , *COLON cancer , *GUT microbiome , *TUMOR markers - Abstract
Astragaloside IV (AS-IV), a natural triterpenoid isolated from
Astragalus membranaceus , has been used traditionally in Chinese medicine. Previous studies have highlighted its benefits against carcinoma, but its interaction with the gut microbiota and effects on adenomatous polyps are not well understood. This present study investigates the effects of AS-IV on colonic adenomatous polyp (CAP) development in high-fat-diet (HFD) fed ApcMin∕+ mice. ApcMin∕+ mice were fed an HFD with or without AS-IV or Naringin for 8 weeks. The study assessed CAP proliferation and employed 16S DNA-sequencing and untargeted metabolomics to explore correlations between microbiome and metabolome in CAP development. AS-IV was more effective than Naringin in reducing CAP development, inhibiting colonic proinflammatory cytokines (IL-1β, IL-6, and TNF-α), tumor associated biomarkers (c-Myc, Cyclin D1), and Wnt/β-catenin pathway proteins (Wnt3a, β-catenin). AS-IV also inhibited the proliferative capabilities of human colon cancer cells (HT29, HCT116, and SW620). Multiomics analysis revealed AS-IV increased the abundance of beneficial genera such asBifidobacterium pseudolongum and significantly modulated serum levels of certain metabolites including linoleate and 2-trans,6-trans-farnesal, which were significantly correlated with the number of CAP. Finally, the anti-adenoma efficacy of AS-IV alone was significantly suppressed post pseudoaseptic intervention in HFD-fed ApcMin∕+ mice but could be reinstated following a combined withBifidobacterium pseudolongum transplant. AS-IV attenuates CAP development in HFD-fed ApcMin∕+ mice by regulating gut microbiota and metabolomics, impacting the Wnt3a/β-catenin signaling pathway. This suggests a potential new strategy for the prevention of colorectal cancer, emphasizing the role of gut microbiota in AS-IV’s antitumor effects. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
15. Nonalcoholic or metabolic-associated fatty liver disease and colorectal polyps: evidence from meta-analysis and two-sample Mendelian randomization.
- Author
-
Dong Zhai, Sumei Xu, Haoge Liu, and Xiaojuan Tong
- Subjects
NON-alcoholic fatty liver disease ,COLON polyps ,ADENOMATOUS polyps ,CHRONIC diseases ,DATABASE searching ,SUBGROUP analysis (Experimental design) - Abstract
Introduction: Nonalcoholic or metabolism-associated fatty liver disease (NAFLD or MAFLD) and colorectal polyps are chronic conditions strongly linked to lifestyle factors. However, the precise causal link between NAFLD or MAFLD and the development of colorectal polyps is not yet fully understood. This study aimed to evaluate the association between NAFLD or MAFLD and the risk of colorectal polyps based on a meta-analysis and two-sample Mendelian randomization (MR) analyses. Methods: PubMed, Embase, Cochrane Library databases were searched for eligible studies to be included in the meta-analysis. We conducted a thorough search of the PubMed, Embase, and Cochrane Library databases to identify eligible studies prior to 22 March 2024. Subgroup analyses were performed based on sex, age, and geographical region. Causality between NAFLD/MAFLD and colorectal polyps was explored by using two-sample Mendelian randomization (MR) analyses. Results: Based on an analysis of 17 studies encompassed within thismeta-analysis, a significant correlation was identified between the presence of NAFLD/MAFLD and elevated incidence of colorectal polyps (NAFLD: OR = 1.57, 95% CI: 1.43-1.73, I² = 38%, p = 0.06; MAFLD: OR = 1.67, 95% CI: 1.40-2.00, I² = 77%, p = 0.002). However, current evidence does not support a causal relationship between NAFLD/MAFLD and the prevalence of colorectal polyps (OR= 0.9998315, 95% CI: 0.9987566-1.000907, P = 0.7587638). Conclusion: NAFLD/MAFLD demonstrated a significant positive correlation with an elevated risk of developing colorectal polyps. However, the MR analysis suggested that no causal relationship existed between NAFLD/MAFLD and colorectal polyps. Therefore, further research is required to identify the underlying mechanism of causal link between these diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
16. Graphene-based synthetic peptide electrochemical sensor for colorectal cancer diagnosis.
- Author
-
Yu, Miao, Li, Quanhui, and Yu, Hualong
- Subjects
PEPTIDOMIMETICS ,BLOOD proteins ,PEPTIDES ,ELECTROCHEMICAL sensors ,GRAPHENE oxide ,ADENOMATOUS polyps - Abstract
This work reports the development of an electrochemical sensor using graphene-peptide conjugates for detecting colorectal cancer (CRC) biomarker leucine-rich alpha-2 glycoprotein-1 (LRG1). To enable LRG1 quantification, we rationally designed peptides with dual graphene anchoring motifs for optimal orientation and binding activity when immobilized on a reduced graphene oxide (rGO) electrochemical transducer surface. The graphene nanomaterial provides several advantages such as high conductivity, large surface area, and excellent stability that can enhance the sensor's analytical performance metrics. Furthermore, the synthetic peptides offer benefits like smaller size, specificity, ease of modification and cost-effective production compared to traditional antibody receptors. Under optimized conditions, the peptide sensor exhibited high sensitivity of 22.3 μA/(ng/mL.cm
2 ), low limit of detection (75 pg/mL LRG1 in serum), accuracy of 101.1 % spiked recovery, and precision within 6 % RSD. Testing with colonoscopy-classified patient serum specimens discriminated normal, precancerous adenomatous polyps and malignant carcinoma stages based on LRG1 overexpression. A 24 % elevation for adenomas and 103 % higher levels in CRC were observed. Validation with spiked plasma samples indicated 97–104 % recovery and <7 % RSD, proving accurate detection capability. Comparison to antibody-based sensors showed superior linear range, sensitivity, reproducibility, and faster assay time. This demonstrates the promise of computational peptide designing combined with advanced nanomaterials for electrochemical detection of CRC progression through serum protein biomarkers. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
17. Determination of optimal dosage of extract of Angelica gigas Nakai against benign prostatic hyperplasia.
- Author
-
Jae Seon Kang and Jin Young Lee
- Subjects
- *
BENIGN prostatic hyperplasia , *CELL morphology , *BLOOD lipids , *KIDNEY physiology , *BLOOD cells , *PROSTATE , *ADENOMATOUS polyps - Abstract
Purpose: To investigate the effect of Angelica gigas Nakai ethanol extract (AGNEX) on benign prostatic hyperplasia (BPH) models induced by castration and testosterone propionate (TP) injection. Methods: 30 rats were randomly divided into six groups of five rats each. One group was used as a normal control (CON) and the other groups were castrated and injected intraperitoneally with TP to induce BPH. Positive control group (PCON) was administered finasteride (5 mg/kg) for 4 weeks and BPH-induced group without treatment was used as negative control (NCON). Groups administered AGNEX (1.25 mg/kg (AG1.25), 5 mg/kg (AG5), or 10 mg/kg (AG10)) instead of finasteride were assigned as study groups. The complete blood cell and lipid profiles, liver and kidney function assays, serum 5α-reductase activity and DHT levels as well as the histological examination of prostate tissues were determined. Results: The prostate volume of AG10 group decreased by approximately 35 % compared to BPH induced group (NCON). The prostate weight ratio decreased by 10 % in BPH + finasteride group compared to NCON group, and by 24 and 22 % in the AG5 and AG10 groups, respectively. AG10 group exhibited the lowest levels of 5α-reductase and dihydrotestosterone. Histopathological observations of prostate tissue showed normal cell shapes and reduced intraluminal polyp formation in the control and AGNEX-administered groups. Conclusion: The administration of 10 mg/kg of AGNEX is optimal dose for protective effect against BPH. Therefore, AGNEX has potentials for further investigations as source of lead agents for BPH management. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
18. 结直肠息肉组织中成纤维细胞生长因子19 和胰岛素样生长因子 1 的表达与结直肠 腺瘤性息肉发生的关系.
- Author
-
王昊, 王海鹏, 姚瑶, 王东洋, 陈明, 孙燕来, 张昊, 董广峰, and 李增军
- Abstract
Objective This investigation sought to delineate the associations among colorectal adenomatous polyps, diabetes, and biomolecules involved in glucose metabolism. Method Data were collected from 40 patients who underwent endoscopic polypectomy at the Endoscopy Department of Shandong Cancer Hospital between June 2019 and September 2021. This cohort included 27 patients with inflammatory polyps and 13 with adenomatous polyps. We assessed fasting insulin (Fins), fasting blood glucose (FBG), and the mRNA expressions of fibroblast growth factor 19 (FGF-19) and insulin-like growth factor 1 (IGF-1) in the polyp tissues. Both univariate and multivariate logistic regression analyses were employed to ascertain the determinants influencing the emergence of adenomatous polyps. From these analyses, a predictive nomogram was constructed to forecast the occurrence of adenomatous polyps, and evaluations on the discriminative capacity, calibration, and clinical utility of the model were conducted. Results The adenomatous polyp group exhibited markedly elevated levels of glucose, insulin, FGF-19, and IGF-1, with respective concentrations of (8.67±2.70) mmol/L, (12.72±7.69) μU/L, 2.20±1.88, and 1.36±0.69. These figures were significantly higher compared to the inflammatory polyp group, which showed levels of (5.51±0.72) mmol/L, (5.49±2.68) μU/L, 0.53±0.97, and 0.41±0.46, respectively, P= 0.001. Multivariate logistic regression revealed that the relative expression of IGF-1 served as an independent risk factor for the development of colorectal adenomatous polyps (OR=5.622, 95% CI: 1.085-29.126). The nomogram displayed a C-index of 0.849, indicating substantial discriminative capability. The calibration curve affirmed the model's accuracy in aligning predicted probabilities with actual outcomes, and the clinical decision curve demonstrated thepractical clinical applicability of the model. Conclusions There was a significant correlation between the occurrence of colorectal adenomatous polyps and glucose metabolic pathways. Individuals with diabetes showed a higher propensity to develop such polyps. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
19. Endocrine Outcomes and Associated Predictive Factors for Somatotrophin Pituitary Adenoma after Endoscopic Endonasal Transsphenoidal Surgery: 10 Years of Experience in a Single Institute.
- Author
-
Geng, Yuanming, Dong, Qian, Cong, Zixiang, Zhu, Junhao, Li, Zhenxing, Du, Chaonan, Yuan, Feng, Zeng, Xinrui, Ali, Alleyar, Yang, Jin, Tang, Chao, and Ma, Chiyuan
- Subjects
- *
ADENOMATOUS polyps , *PITUITARY tumors , *SOMATOMEDIN C , *SOMATOTROPIN , *ENTEROENDOCRINE cells , *LOGISTIC regression analysis , *REGRESSION analysis - Abstract
Objective Biochemical remission rates of endoscopic endonasal transsphenoidal surgery (EETS) and its associated predictive factors were evaluated in patients with somatotrophin pituitary adenomas. Methods The patients who underwent EETS in Jinling Hospital were identified between 2011 and 2020. The surgeons' experience, preoperative insulin-like growth factor 1 (IGF-1), basal growth hormone (GH) levels, nadir GH levels, and the tumor characteristics were analyzed for their relationships with endocrine outcomes. Total 98 patients were included for single factor analysis and regression analysis. They were divided into three groups according to the admission chronologic order. Results The overall remission rate of the patients was 57% (56/98) for all the patients over 10 years. In the single factor analysis, we found that the tumor size, cavernous invasion, and sellar invasion were valuable to predict the endocrine outcome after surgery. As for the suprasellar invasion, no significant difference was found between the noninvasive group and the invasive group. The preoperative IGF-1 level (p = 0.166), basal GH level (p = 0.001), and nadir GH level (p = 0.004) were also different between the remission group and the nonremission group in the single factor analysis. The logistic regression analysis indicated that the preoperative nadir GH (odds ratio = 0.930, 95% confidence interval = 0.891–0.972, p = 0.001) was a significant predictor for the endocrine outcomes after surgery. Conclusion The surgeons' experience is an important factor that can affect the patients' endocrine outcomes after surgery. The macroadenomas with lateral invasion are more difficult to cure. Patients with higher preoperative nadir GH levels are less likely to achieve remission. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
20. Immunomodulatory effects of live and UV-killed Bacillus subtilis natto on inflammatory response in human colorectal adenocarcinoma cell line in vitro.
- Author
-
Elkhichi, Parisa Abedi, Aslanimehr, Masoumeh, Javadi, Amir, and Yadegar, Abbas
- Subjects
- *
BACILLUS subtilis , *RECTAL diseases , *GENE expression , *PSEUDOPOTENTIAL method , *COLON diseases , *ADENOMATOUS polyps - Abstract
Background and Objectives: Colorectal cancer (CRC) is a heterogeneous disease of the colon or rectum arising from adenoma precursors and serrated polyps. Recently, probiotics have been proposed as an effective and potential therapeutic approach for CRC prevention and treatment. Probiotics have been shown to alleviate inflammation by restoring the integrity of the mucosal barrier and impeding cancer progression. Materials and Methods: In this study, we aimed to investigate the immunomodulatory effects of live and UV-killed Bacillus subtilis natto on the inflammatory response in CRC. Caco-2 cells were exposed to various concentrations of live and UVkilled B. subtilis natto, and cell viability was assessed using MTT assay. Gene expression analysis of IL-10, TGF-β, TLR2 and TLR4 was performed using RT-qPCR. Results: Our findings showed that both live and UV-killed B. subtilis natto caused significant reduction in inflammatory response by decreasing the gene expression of TLR2 and TLR4, and enhancing the gene expression of IL-10 and TGF-β in Caco-2 cells as compared to control group. Conclusion: The results of this study suggest that live and UV-killed B. subtilis natto may hold potential as a therapeutic supplement for modulating inflammation in CRC. [ABSTRACT FROM AUTHOR]
- Published
- 2024
21. MicroRNA-193a-3p as a Valuable Biomarker for Discriminating between Colorectal Cancer and Colorectal Adenoma Patients.
- Author
-
Fabijanec, Marija, Hulina-Tomašković, Andrea, Štefanović, Mario, Verbanac, Donatella, Ćelap, Ivana, Somborac-Bačura, Anita, Grdić Rajković, Marija, Demirović, Alma, Ramić, Snježana, Krušlin, Božo, Rumora, Lada, Čeri, Andrea, Koržinek, Martha, Petrik, József, Ljubičić, Neven, Baršić, Neven, and Barišić, Karmela
- Subjects
- *
CARCINOEMBRYONIC antigen , *COLORECTAL cancer , *TUMOR markers , *RECEIVER operating characteristic curves , *LOGISTIC regression analysis , *ADENOMATOUS polyps - Abstract
Specific markers for colorectal cancer (CRC), preceded by colorectal adenoma (pre-CRC), are lacking. This study aimed to investigate whether microRNAs (miR-19a-3p, miR-92a-3p, miR-193a-3p, and miR-210-3p) from tissues and exosomes are potential CRC biomarkers and compare them to existing biomarkers, namely carcinoembryonic antigen (CEA) and carbohydrate antigen (CA) 19-9. MiRNA was isolated in the samples of 52 CRC and 76 pre-CRC patients. Expression levels were analyzed by RT-qPCR. When comparing pre-CRC and CRC tissue expression levels, only miR-193a-3p showed statistically significant result (p < 0.0001). When comparing the tissues and exosomes of CRC samples, a statistically significant difference was found for miR-193a-3p (p < 0.0001), miR-19a-3p (p < 0.0001), miR-92a-3p (p = 0.0212), and miR-210-3p (p < 0.0001). A receiver-operating characteristic (ROC) curve and area under the ROC curve (AUC) were used to evaluate the diagnostic value of CEA, CA 19-9, and miRNAs. CEA and CA 19-9 had good diagnostic values (AUCs of 0.798 and 0.668). The diagnostic value only of miR-193a-3p was highlighted (AUC = 0.725). The final logistic regression model, in which we put a combination of CEA concentration and the miR-193a-3p expression level in tissues, showed that using these two markers can distinguish CRC and pre-CRC in 71.3% of cases (AUC = 0.823). MiR-193a-3p from tissues could be a potential CRC biomarker. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
22. Muir–Torre syndrome in Fitzpatrick skin phototype V assessed by dermoscopy and reflectance confocal microscopy.
- Author
-
Orloff, Jeremy, Cabral, Patricia, Zhou, Lisa, Piontkowski, Austin J., Powers, Camille M., Niedt, George, Farnetani, Francesca, and Gulati, Nicholas
- Subjects
- *
HEREDITARY nonpolyposis colorectal cancer , *DISEASE risk factors , *SKIN tumors , *BASAL cell carcinoma , *CONFOCAL microscopy , *ADENOMATOUS polyps , *FAT cells - Abstract
This article discusses a case of Muir-Torre Syndrome (MTS), a variant of hereditary non-polyposis colorectal cancer (HNPCC) syndrome, in a 46-year-old man with Fitzpatrick skin phototype V. MTS is characterized by cutaneous sebaceous tumors and keratoacanthomas, and is caused by mutations in genes involved in the mismatch repair system. The patient had a family history of HNPCC and sebaceous carcinomas, and had previously undergone genetic testing. The article describes the clinical presentation, dermoscopy findings, reflectance confocal microscopy (RCM) findings, and histopathology of the patient's lesions. It also discusses the challenges of diagnosing and differentiating sebaceoma using dermoscopy and RCM, particularly in skin of color. The authors suggest that RCM can be a useful adjunctive diagnostic tool for sebaceous tumors and call for further research on rare tumor types in skin of color. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
23. The Impact of potential ‘confounders’ on the diagnostic sensitivity of circulating free DNA in management of FIT+ patients: a pilot study.
- Author
-
Scimia, Mauro, Pepe, Francesco, Russo, Gianluca, Palumbo, Lucia, Malapelle, Umberto, Chuang, Rachel, Scimia, Simone, Sha, Michael, Hiromi Tanaka, Shuo Shen, Chen, David, Troncone, Giancarlo, and Bianco, Maria Antonia
- Subjects
CIRCULATING tumor DNA ,CELL-free DNA ,SMALL cell lung cancer ,SOMATIC mutation ,RAS oncogenes ,BLOOD coagulation tests ,ADENOMATOUS polyps - Published
- 2024
- Full Text
- View/download PDF
24. Optimal glycaemic control and the reduced risk of colorectal adenoma and cancer in patients with diabetes: a population-based cohort study.
- Author
-
Xianhua Mao, Ka Shing Cheung, Jing-Tong Tan, Lung-Yi Mak, Chi-Ho Lee, Chi-Leung Chiang, Ho Ming Cheng, Rex Wan-Hin Hui, Man Fung Yuen, Wai Keung Leung, and Wai-Kay Seto
- Subjects
CONTINUOUS glucose monitoring ,LIFE sciences ,GLYCEMIC control ,GLUCAGON-like peptide-1 receptor ,NOSOLOGY ,ADENOMATOUS polyps ,HEART failure - Published
- 2024
- Full Text
- View/download PDF
25. Genome and tissue-specific transcriptomes of the large-polyp coral, Fimbriaphyllia (Euphyllia) ancora: a recipe for a coral polyp.
- Author
-
Shikina, Shinya, Yoshioka, Yuki, Chiu, Yi-Ling, Uchida, Taiga, Chen, Emma, Cheng, Yin-Chu, Lin, Tzu-Chieh, Chu, Yu-Ling, Kanda, Miyuki, Kawamitsu, Mayumi, Fujie, Manabu, Takeuchi, Takeshi, Zayasu, Yuna, Satoh, Noriyuki, and Shinzato, Chuya
- Subjects
- *
CORALS , *TRANSCRIPTOMES , *DIGESTIVE enzymes , *DEEP-sea corals , *NATURAL immunity , *ADENOMATOUS polyps - Abstract
Coral polyps are composed of four tissues; however, their characteristics are largely unexplored. Here we report biological characteristics of tentacles (Te), mesenterial filaments (Me), body wall (Bo), and mouth with pharynx (MP), using comparative genomic, morpho-histological, and transcriptomic analyses of the large-polyp coral, Fimbriaphyllia ancora. A draft F. ancora genome assembly of 434 Mbp was created. Morpho-histological and transcriptomic characterization of the four tissues showed that they have distinct differences in structure, primary cellular composition, and transcriptional profiles. Tissue-specific, highly expressed genes (HEGs) of Te are related to biological defense, predation, and coral-algal symbiosis. Me expresses multiple digestive enzymes, whereas Bo expresses innate immunity and biomineralization-related molecules. Many receptors for neuropeptides and neurotransmitters are expressed in MP. This dataset and new insights into tissue functions will facilitate a deeper understanding of symbiotic biology, immunology, biomineralization, digestive biology, and neurobiology in corals. A draft genome and tissue-specific transcriptome assemblies of the large-polyp coral, Fimbriaphyllia ancora were established. This dataset and new insights into tissue functions will facilitate a deeper understanding of coral biology. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
26. Different modifiable risk factors for the development of non-advanced adenoma, advanced adenomatous lesion, and sessile serrated lesions, on screening colonoscopy.
- Author
-
Choe, A. Reum, Song, Eun Mi, Seo, Heeju, Kim, Hyunju, Kim, Gyuri, Kim, Sojin, Byeon, Ju Ran, Park, Yehyun, Tae, Chung Hyun, Shim, Ki-Nam, and Jung, Sung-Ae
- Subjects
- *
ADENOMATOUS polyps , *MEDICAL screening , *ADENOMA , *SMOKING cessation , *COLON polyps , *METABOLIC syndrome - Abstract
The development of premalignant colorectal polyps is significantly influenced by various lifestyle and modifiable risk factors. In our study, we used a large cohort of 9025 patients, who underwent screening colonoscopies at a university hospital, to assess the risk factors associated with the development of three different colorectal cancer precursor lesions: non-advanced adenomas (NAs), advanced adenomatous lesions (ADLs), and sessile serrated lesions (SSLs). Among the participants, 3641 had NAs, 836 had ADLs, and 533 had SSLs. We identified obesity, current smoking, and appendicular skeletal muscle mass as modifiable lifestyle risk factors that increase the development of NAs and ADLs (all P < 0.05). Furthermore, we found a positive correlation between the degree of obesity and an increased risk of developing NAs and ADLs (all P for trend < 0.001), while non-smoking was associated with a decreased risk (P for trend < 0.001 and 0.003, respectively). Smoking was the only modifiable risk factor for developing SSLs (adjusted odds ratio [aOR] 1.58; 95% confidence interval [CI] 1.20–2.07), and the risk was even higher in patients with metabolic syndrome (aOR 1.71; 95% CI 1.05–2.77). Addressing modifiable lifestyle factors such as smoking and obesity could play an important role in reducing the risk of both non-advanced and advanced adenomatous lesions. Smoking cessation is especially important as it is a significant modifiable risk factor for sessile serrated lesions. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
27. Evolutionary history of adenomas to colorectal cancer in FAP families.
- Author
-
Cuiping Yang, Enfei Xiang, Ping Chen, and Xuqian Fang
- Subjects
ADENOMATOUS polyps ,ADENOMATOUS polyposis coli ,COLORECTAL cancer ,ADENOMA ,DNA repair ,ENDOSCOPIC surgery - Abstract
Objective: Familial adenomatous polyposis (FAP) is a genetic syndrome characterized by multiple polyps at various evolutionary stages, which, if left untreated, inevitably progress to colorectal cancer (CRC). In this study, we present a comprehensive analysis of the evolutionary history of FAP-CRC from precancerous adenoma to carcinoma. Design: Tissues were collected from gastrointestinal endoscopy or surgical resection. Exome sequencing was performed on multiple regions of adenocarcinoma (n = 8), villous adenoma (n = 10), tubular adenoma (n = 9) and blood samples were obtained from 9 patients belonging to 7 Chinese FAP families. Phylogenetic trees were reconstructed, and evolutionary analysis was conducted to reveal the temporal sequence of events leading to CRC. Results: Inherited germline mutation sites in APC gene were identified in FAP01 (p.S1281*, COSM19212), FAP03 (p.S384Tfs*19), FAP04 (p.E1538*, COSM6041693), FAP05 (p.Q1062*, COSM3696862), and FAP07-FAP09 (p.V677Sfs*3). Notably, p.V677Sfs*3 mutation was recognized as a novel germline mutation in APC, supported by evidence of genotype-phenotype correlation in pedigree analysis. Adenomas exhibited lower mutational rates than FAP-CRC and displayed recurrent alterations in well-known chromosomal instability (CIN) genes (APC, RAS, SMAD4 and TP53) and DNA damage repair genes (SUZ12, KMT2C, BCLAF1, RUNX1, and ARID1B), suggesting the presence of genomic instability. Furthermore, a progressive increase in the HRD score (a measure of "genomic scars") was observed from tubular adenomas to villous adenomas and ultimately to carcinomas. TP53 emerged as the primary driver gene for adenoma-carcinoma transition, with driver mutations consistently appearing simultaneously rather than sequentially acquired from adenomas to carcinomas. Clonal evolution demonstrated that liver metastases can originate from the same cancer-primed cell present in a primary cancerous lesion. Conclusion: We identified a novel pathogenic variant in APC, namely, p.V677Sfs*3. The process of carcinogenesis in FAP-CRC supports the classical cancerization model, where an initial APC mutation leads to the activation of the WNT signaling pathway and CIN. Subsequently, additional mutations occur in other putative CIN genes (e.g., DNA repair, chromatin remodeling), ultimately leading to the development of microsatellite stable (MSS) tumors. Our study provides a comprehensive understanding of the genomic landscapes that underlie the transition from adenoma to carcinoma. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
28. Clinical and Molecular Characterization of SMAD4 Splicing Variants in Patients with Juvenile Polyposis Syndrome.
- Author
-
Forte, Giovanna, Buonadonna, Antonia Lucia, Fasano, Candida, Sanese, Paola, Cariola, Filomena, Manghisi, Andrea, Guglielmi, Anna Filomena, Lepore Signorile, Martina, De Marco, Katia, Grossi, Valentina, Disciglio, Vittoria, and Simone, Cristiano
- Subjects
- *
RNA splicing , *SMAD proteins , *ADENOMATOUS polyps , *GENETIC counseling , *GENETIC variation , *RNA analysis , *FRAMESHIFT mutation - Abstract
Juvenile polyposis syndrome (JPS) is an inherited autosomal dominant condition that predisposes to the development of juvenile polyps throughout the gastrointestinal (GI) tract, and it poses an increased risk of GI malignancy. Germline causative variants were identified in the SMAD4 gene in a subset (20%) of JPS cases. Most SMAD4 germline genetic variants published to date are missense, nonsense, and frameshift mutations. SMAD4 germline alterations predicted to result in aberrant splicing have rarely been reported. Here, we report two unrelated Italian families harboring two different SMAD4 intronic variants, c.424+5G>A and c.425-9A>G, which are clinically associated with colorectal cancer and/or juvenile GI polyps. In silico prediction analysis, in vitro minigene assays, and RT-PCR showed that the identified variants lead to aberrant SMAD4 splicing via the exonization of intronic nucleotides, resulting in a premature stop codon. This is expected to cause the production of a truncated protein. This study expands the landscape of SMAD4 germline genetic variants associated with GI polyposis and/or cancer. Moreover, it emphasizes the importance of the functional characterization of SMAD4 splicing variants through RNA analysis, which can provide new insights into genetic disease variant interpretation, enabling tailored genetic counseling, management, and surveillance of patients with GI polyposis and/or cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
29. Repurposing cyclovirobuxine D as a novel inhibitor of colorectal cancer progression via modulating the CCT3/YAP axis.
- Author
-
Liu, Yiman, Chen, Lu, Wang, Jinghui, Bao, Xiaomei, Huang, Jiayan, Qiu, Yuling, Wang, Tao, and Yu, Haiyang
- Subjects
- *
COLORECTAL cancer , *ADENOMATOUS polyps , *CANCER invasiveness , *TREATMENT effectiveness , *AUTOPHAGY , *CELLULAR aging , *DEXTRAN , *IRINOTECAN - Abstract
Background and Purpose Experimental Approach Key Results Conclusions and Implications Colorectal cancer (CRC) ranks second in mortality worldwide and requires effective and affordable remedies. Cyclovirobuxine D (CVB‐D) is the main effective component of Huangyangning tablet, an approved traditional patent medicine, which is mainly used for cardiovascular treatment. As a multibioactive natural compound, CVB‐D possesses underlying anticancer activities.Cell viability and clone‐forming ability were determined in human CRC lines. Western blot, immunofluorescence assay, transmission electron microscopy and senescence‐associated β‐galactosidase (SA‐β‐Gal) staining were utilized to investigate cell autophagy and senescence. The molecular mechanisms were explored by virtual prediction and experimental validation. Patient‐derived xenograft (PDX), dextran sulfate sodium salt (DSS), and azomethane (AOM)/DSS mouse models were employed for in vivo studies.CVB‐D inhibited the growth and development of advanced CRC cells / mice by inducing autophagic and senescent activities through the chaperonin containing TCP1 subunit 3 (CCT3)/yes‐associated protein (YAP) axis. CVB‐D acted as a promising inhibitor of CCT3 by interacting with its ATP site. In PDX tumours, CVB‐D showed potential therapeutic effects by targeting CCT3. Treatment with CVB‐D alleviated the mouse model of colitis induced by DSS and attenuated AOM/DSS‐induced formation of adenomatous polyps by its action on CCT3.Our study has provided a scientific basis for the suggestion that CVB‐D may be recognized as a prospective drug candidate for the therapy of CRC in patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
30. Detection of colorectal‐cancer‐associated bacterial taxa in fecal samples using next‐generation sequencing and 19 newly established qPCR assays.
- Author
-
Senthakumaran, Thulasika, Tannæs, Tone M., Moen, Aina E. F., Brackmann, Stephan A., Jahanlu, David, Rounge, Trine B., Bemanian, Vahid, and Tunsjø, Hege S.
- Subjects
- *
NUCLEOTIDE sequencing , *ADENOMATOUS polyps , *RIBOSOMAL RNA , *COLORECTAL cancer , *CANCER patients , *FUSOBACTERIUM - Abstract
We have previously identified increased levels of distinct bacterial taxa within mucosal biopsies from colorectal cancer (CRC) patients. Following prior research, the aim of this study was to investigate the detection of the same CRC‐associated bacteria in fecal samples and to evaluate the suitability of fecal samples as a non‐invasive material for the detection of CRC‐associated bacteria. Next‐generation sequencing (NGS) of the 16S ribosomal RNA (rRNA) V4 region was performed to evaluate the detection of the CRC‐associated bacteria in the fecal microbiota of cancer patients, patients with adenomatous polyp and healthy controls. Furthermore, 19 novel species‐specific quantitative PCR (qPCR) assays were established to detect the CRC‐associated bacteria. Approximately, 75% of the bacterial taxa identified in biopsies were reflected in fecal samples. NGS failed to detect low‐abundance CRC‐associated taxa in fecal samples, whereas qPCR exhibited high sensitivity and specificity in identifying all targeted taxa. Comparison of fecal microbial composition between the different patient groups showed enrichment of Fusobacterium nucleatum, Parvimonas micra, and Gemella morbillorum in cancer patients. Our findings suggest that low‐abundance mucosa‐associated bacteria can be detected in fecal samples using sensitive qPCR assays. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
31. A semantic feature enhanced YOLOv5-based network for polyp detection from colonoscopy images.
- Author
-
Wan, Jing-Jing, Zhu, Peng-Cheng, Chen, Bo-Lun, and Yu, Yong-Tao
- Subjects
- *
ADENOMATOUS polyps , *POLYPS , *COLONOSCOPY , *ADENOMA , *DIGESTIVE organs , *COLORECTAL cancer - Abstract
Colorectal cancer (CRC) is a common digestive system tumor with high morbidity and mortality worldwide. At present, the use of computer-assisted colonoscopy technology to detect polyps is relatively mature, but it still faces some challenges, such as missed or false detection of polyps. Therefore, how to improve the detection rate of polyps more accurately is the key to colonoscopy. To solve this problem, this paper proposes an improved YOLOv5-based cancer polyp detection method for colorectal cancer. The method is designed with a new structure called P-C3 incorporated into the backbone and neck network of the model to enhance the expression of features. In addition, a contextual feature augmentation module was introduced to the bottom of the backbone network to increase the receptive field for multi-scale feature information and to focus on polyp features by coordinate attention mechanism. The experimental results show that compared with some traditional target detection algorithms, the model proposed in this paper has significant advantages for the detection accuracy of polyp, especially in the recall rate, which largely solves the problem of missed detection of polyps. This study will contribute to improve the polyp/adenoma detection rate of endoscopists in the process of colonoscopy, and also has important significance for the development of clinical work. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
32. Concentration and Composition of Circulating Adipocyte-Derived Extracellular Vesicles in Patients with Colonic Polyps and Colorectal Cancer.
- Author
-
Yunusova, N. V., Svarovsky, D. A., Kolegova, E. S., Cheremisina, O. V., Kostromitsky, D. N., Kondakova, I. V., Sidenko, E. A., Dobrodeev, A. Yu., and Grigor'eva, A. E.
- Subjects
- *
METABOLIC syndrome , *EXTRACELLULAR vesicles , *METABOLIC disorders , *COLON polyps , *COLORECTAL cancer , *ADENOMATOUS polyps - Abstract
Extracellular vesicles (EVs) are a heterogeneous population of membrane-bound nanoparticles (< 1 µm in size) secreted by various cell types. Most of EVs circulating in human blood are derived from platelets, leukocytes, erythrocytes, and endotheliocytes. The composition of circulating adipocyte-derived EVs under various pathological conditions has been virtually unknown. Small EVs were isolated by ultrafiltration and double ultracentrifugation from blood plasma of patients with colorectal cancer (CRC) and colonic polyps with obesity or metabolic syndrome. The composition of adipocyte-derived EVs was analyzed by immunoprecipitation combined with Western blotting and flow cytometry. EVs fractions (FABP4- and CD11b-immunoprecipitated EVs, as well as EVs contained in the supernatant after removal of CD11b-positive EVs) contained a complex of adipocyte markers (FABP4, PPAR-γ, perilipin 1). In CRC patients without obesity, monocyte/macrophage-derived EVs precipitated on CD11b-coated particles were characterized by a combined overexpression of FABP4 and perilipin 1, while such an overexpression was not typical for CRC patients with metabolic syndrome or obesity. The fraction of true adipocyte-derived EVs (supernatant after removal of CD11b-positive EVs) was characterized by the presence of a complex of adipocyte markers with a predominant expression of FABP4 in all patients both with metabolic syndrome/metabolically healthy obesity and without metabolic disorders. To correctly characterize circulating EVs in patients without obesity, it is necessary first to remove the fraction of CD11b-positive monocyte/macrophage-derived EVs from EV preparations by immunoprecipitation or similar methods, and then, after removal/sorption of precipitated EVs, to analyze the composition of adipocyte-derived EVs in the supernatant using a set of above-mentioned adipocyte markers. Moreover, in patients with metabolic disorders, given the insignificant FABP4 expression in CD11b-immunoprecipitated EVs, the pre-depletion of EV preparations does not appear to be that necessary. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
33. Tackling Challenges in Assessing the Economic Value of Tumor-Agnostic Therapies: A Cost-Effectiveness Analysis of Pembrolizumab as a Case Study.
- Author
-
Chen, Yilin, Martin, Peter, Inoue, Lurdes Y.T., Basu, Anirban, and Carlson, Josh J.
- Subjects
- *
VALUE (Economics) , *SMALL intestine cancer , *HEALTH systems agencies , *PEMBROLIZUMAB , *TREATMENT effect heterogeneity , *ADENOMATOUS polyps - Abstract
Assessing the value of tumor-agnostic drugs (TAD) is challenging given the potential variability in treatment effects, trials with small sample sizes, different standards of care (SoC), and lack of comparative data from single-arm basket trials. Our study developed and applied novel methods to assess the value of pembrolizumab compared with SoC to inform coverage decisions. We developed a partitioned survival model to evaluate the cost-utility of pembrolizumab for previously treated patients with 8 advanced or metastatic microsatellite instability-high or mismatch repair-deficient cancers from a US commercial payer perspective. Efficacy of pembrolizumab was based on data from trials directly or with adjustment using Bayesian hierarchical models. Eight chemotherapy-based external control arms were constructed from the TriNetX electronic health record databases. Tumor-specific health-state utility values were applied. All costs were adjusted to 2022 US dollars. At a lifetime horizon, pembrolizumab was associated with increased effectiveness compared with chemotherapies in colorectal (quality-adjusted life years [QALYs]: +0.64, life years [LYs]: +0.64), endometrial (QALYs: +3.79, LYs: +5.47), and small intestine cancers (QALYs: +1.73, LYs: +2.48), but not for patients with metastatic gastric, cholangiocarcinoma, pancreatic, ovarian, and brain cancers. Incremental cost-effectiveness ratios varied substantially across tumor types. Pembrolizumab was found to be cost-effective in treating colorectal and endometrial cancers (incremental cost-effectiveness ratios: $121 967 and $139 257, respectively), and not cost-effective for other assessed cancers at a $150 000 willingness-to-pay/QALY threshold, compared with SoC chemotherapies. The cost-effectiveness of TADs can vary by cancers. Using analytic tools such as external controls and Bayesian hierarchical models can tackle several challenges in assessing the value of TADs and uncertainties from basket trials. • Tumor-agnostic or histology-independent therapies have the potential to greatly benefit patients with limited therapeutic alternatives. Health technology assessment (HTA) agencies across health systems have detailed major challenges for value assessments of tumor-agnostic drugs, such as the potential for heterogeneity in treatment effect, the lack of comparative data due to single-arm studies, variable standards of care (SoC) across tumor types, and large uncertainty in the evidence base available to inform coverage and reimbursement decisions. • This cost-effectiveness analysis of pembrolizumab against SoC chemotherapies in 8 microsatellite instability-high or mismatch repair-deficient metastatic cancers demonstrated varying incremental cost-effectiveness ratios across tumor types. Pembrolizumab was found to be cost-effective for previously treated colorectal and endometrial cancers, but not for other evaluated cancers, when compared to SoC chemotherapies, using a $150 000 willingness-to-pay/quality-adjusted life years threshold. • We demonstrated the potential to address several challenges in using evidence from single-arm basket trials in HTA by leveraging Bayesian Hierarchical Modeling approach and real-world data-based external controls. This approach informs future HTA methodology development and payer coverage decisions for tumor-agnostic indications. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
34. Serrated Polyps in Inflammatory Bowel Disease Indicate a Similar Risk of Metachronous Colorectal Neoplasia as in the General Population.
- Author
-
Medawar, Edgard, Djinbachian, Roupen, Crainic, Ioana Popescu, Safih, Widad, Battat, Robert, Mccurdy, Jeffrey, Lakatos, Peter L., and von Renteln, Daniel
- Subjects
- *
INFLAMMATORY bowel diseases , *POLYPS , *TUMORS , *ADENOMATOUS polyps , *HEREDITARY nonpolyposis colorectal cancer - Abstract
Background: The risk of metachronous advanced neoplasia after diagnosing serrated polyps in patients with IBD is poorly understood. Methods: A retrospective multicenter cohort study was conducted between 2010 and 2019 at three tertiary centers in Montreal, Canada. From pathology databases, we identified 1587 consecutive patients with serrated polyps (sessile serrated lesion, traditional serrated adenoma, or serrated epithelial change). We included patients aged 45–74 and excluded patients with polyposis, colorectal cancer, or no follow-up. The primary outcome was the risk of metachronous advanced neoplasia (advanced adenoma, advanced serrated lesion, or colorectal cancer) after index serrated polyp, comparing patients with and without IBD. Results: 477 patients with serrated polyps were eligible (mean age 61 years): 37 with IBD, totaling 45 serrated polyps and 440 without IBD, totaling 586 serrated polyps. The median follow-up was 3.4 years. There was no difference in metachronous advanced neoplasia (HR 0.77, 95% CI 0.32–1.84), metachronous advanced adenoma (HR 0.54, 95% CI 0.11–2.67), and metachronous advanced serrated lesion (HR 0.76, 95% CI 0.26–2.18) risk. When comparing serrated polyps in mucosa involved or uninvolved with IBD, both groups had similar intervals from IBD to serrated polyp diagnosis (p > 0.05), maximal therapies (p > 0.05), mucosal inflammation, inflammatory markers, and fecal calprotectin (p > 0.05). Conclusion: The risk of metachronous advanced neoplasia after serrated polyp detection was similar in patients with and without IBD. Serrated polyps in IBD occurred independently of inflammation. This helps inform surveillance intervals for patients with IBD diagnosed with serrated polyps. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
35. Cost‐effectiveness analysis of single colonoscopy versus single fecal test for colorectal cancer diagnosis and treatment.
- Author
-
Ishibashi, Fumiaki, Suzuki, Sho, Kobayashi, Konomi, Tanaka, Ryu, Kawakami, Tomohiro, Mochida, Kentaro, Nagai, Mizuki, Ishibashi, Yuichi, and Morishita, Tetsuo
- Subjects
- *
FECAL occult blood tests , *COLORECTAL cancer , *CANCER diagnosis , *COLONOSCOPY , *MEDICAL screening , *COST effectiveness , *ISCHEMIC colitis , *ADENOMATOUS polyps - Abstract
Background and Aim: Regular endoscopy or fecal immunochemical test (FIT) is ideal for screening colorectal cancer. However, only a limited number of individuals undergo regular screening. This study aimed to compare the cost‐effectiveness of a single colonoscopy with a single FIT performed for colorectal cancer screening. Methods: A microsimulation model was constructed based on real‐world observational data collected from three institutions between 2019 and 2022 that compared colonoscopy‐based screening with FIT‐based screening. The total costs of diagnosis and treatment of the detected lesions using the two strategies were calculated. The incremental cost‐effectiveness ratio (ICER) per life year gained (LYG) of the colonoscopy‐based strategy was calculated. Results: Data from 11 407 patients undergoing colonoscopies and 59 176 patients undergoing FITs were used to establish a model. In the base case analysis of screening strategies, colonoscopy was more cost‐effective than FIT (ICER 415 193 yen/LYG). The ICER of the colonoscopy‐based strategy among 60‐ to 69‐year‐old patients was lowest at 394 200 yen/LYG, whereas that in 20‐ to 29‐year‐old patients was highest. Monte Carlo simulations showed that the colonoscopy‐based strategy was more cost‐effective than the FIT‐based strategy (net monetary benefit [NMB]: 5 695 957 yen vs 5 348 253 yen). When the adenoma detection rate in the colonoscopy was over 30% or the positive FIT rate was lower than 8.6% in the FIT‐based strategy, the NMB of the colonoscopy‐based strategy exceeded that of the FIT‐based strategy. Conclusion: In the microsimulation model, colonoscopy is recommended as a one‐time screening procedure in patients aged >60 years with >30% ADR or <8.6% positive FIT rate. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
36. Use of a Novel Artificial Intelligence System Leads to the Detection of Significantly Higher Number of Adenomas During Screening and Surveillance Colonoscopy: Results From a Large, Prospective, US Multicenter, Randomized Clinical Trial.
- Author
-
Desai, Madhav, Ausk, Karlee, Brannan, Donald, Chhabra, Rajiv, Chan, Walter, Chiorean, Michael, Gross, Seth A., Girotra, Mohit, Haber, Gregory, Hogan, Reed B., Jacob, Bobby, Jonnalagadda, Sreeni, Iles-Shih, Lulu, Kumar, Navin, Law, Joanna, Lee, Linda, Lin, Otto, Mizrahi, Meir, Pacheco, Paulo, and Parasa, Sravanthi
- Subjects
- *
VIRTUAL colonoscopy , *MEDICAL screening , *ARTIFICIAL intelligence , *COLONOSCOPY , *CLINICAL trials , *ADENOMA , *ADENOMATOUS polyps , *COLON polyps - Abstract
INTRODUCTION: Adenoma per colonoscopy (APC) has recently been proposed as a quality measure for colonoscopy. We evaluated the impact of a novel artificial intelligence (AI) system, compared with standard high-definition colonoscopy, for APC measurement. METHODS: This was a US-based, multicenter, prospective randomized trial examining a novel AI detection system (EW10-EC02) that enables a real-time colorectal polyp detection enabled with the colonoscope (CAD-EYE). Eligible average-risk subjects (45 years or older) undergoing screening or surveillance colonoscopy were randomized to undergo either CAD-EYE-assisted colonoscopy (CAC) or conventional colonoscopy (CC). Modified intention-to-treat analysis was performed for all patients who completed colonoscopy with the primary outcome of APC. Secondary outcomes included positive predictive value (total number of adenomas divided by total polyps removed) and adenoma detection rate. RESULTS: In modified intention-to-treat analysis, of 1,031 subjects (age: 59.1 6 9.8 years; 49.9% male), 510 underwent CAC vs 523 underwent CC with no significant differences in age, gender, ethnicity, or colonoscopy indication between the 2 groups. CAC led to a significantly higher APC compared with CC: 0.9961.6 vs 0.8561.5, P50.02, incidence rate ratio 1.17 (1.03-1.33, P50.02) with no significant difference in the withdrawal time: 11.28 6 4.59 minutes vs 10.8 6 4.81 minutes; P50.11 between the 2 groups. Difference in positive predictive value of a polyp being an adenoma among CAC and CC was less than 10% threshold established: 48.6% vs 54%, 95% CI 29.56% to 21.48%. There were no significant differences in adenoma detection rate (46.9% vs 42.8%), advanced adenoma (6.5% vs 6.3%), sessile serrated lesion detection rate (12.9% vs 10.1%), and polyp detection rate (63.9% vs 59.3%) between the 2 groups. There was a higher polyp per colonoscopy with CAC compared with CC: 1.68 6 2.1 vs 1.33 6 1.8 (incidence rate ratio 1.27; 1.15-1.4; P < 0.01). DISCUSSION: Use of a novel AI detection system showed to a significantly higher number of adenomas per colonoscopy compared with conventional high-definition colonoscopy without any increase in colonoscopy withdrawal time, thus supporting the use of AI-assisted colonoscopy to improve colonoscopy quality (ClinicalTrials. gov NCT04979962). [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
37. E‐Posters.
- Subjects
- *
ADENOMATOUS polyps , *SARCOPENIA , *FEVER , *LEUKOCYTE count , *DIGESTIVE system diseases , *THIRD harmonic generation , *LASER endoscopy - Abstract
This document is a collection of abstracts from the journal Digestive Endoscopy, covering a wide range of topics related to endoscopic procedures and treatments for gastrointestinal conditions. The studies evaluate the effectiveness and safety of different techniques, such as narrow-band imaging and magnifying endoscopy, and highlight the positive outcomes and low complication rates associated with these procedures. However, further research is needed to optimize the techniques and improve long-term outcomes. The document also includes summaries of studies and case reports on specific topics, such as colorectal cancer, liver and pancreatic diseases, and pediatric gastroenterology. These resources provide valuable insights for library patrons conducting research in these areas. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
38. Outstanding Posters.
- Subjects
- *
ADENOMATOUS polyps , *MEDICAL waste disposal , *WOUND healing , *BILE , *MACHINE learning , *CONVOLUTIONAL neural networks - Abstract
This document provides concise summaries of research studies presented at a medical conference on digestive endoscopy. The studies explore various topics, such as the effectiveness of different procedures for treating gastric conditions and the use of artificial intelligence in diagnosing gastrointestinal diseases. While the studies offer valuable insights into the safety and potential benefits of these interventions, further research is needed to validate their findings and assess their impact on patient care. The document also includes studies on endoscopic procedures for other gastrointestinal conditions, contributing to the understanding and improvement of endoscopic techniques and interventions. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
39. Oral Presentations.
- Subjects
- *
ADENOMATOUS polyps , *ARTIFICIAL neural networks , *MACHINE learning - Abstract
This document provides summaries of various research studies related to digestive endoscopy. The studies cover topics such as the diagnostic accuracy of artificial intelligence models in identifying anatomical structures, management strategies for pancreatic necrosis, the use of artificial intelligence in colonoscopy, the efficacy of hemostatic powder in preventing bleeding, the outcomes of endoscopic resection for gastric cancers, and the effectiveness of preventive defect closure after endoscopic papillectomy. The summaries highlight the findings and conclusions of each study, providing valuable insights for library patrons conducting research on these specific topics. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
40. Incidence and risk factors for recurrence of ampullary adenomas after endoscopic papillectomy: Comparative analysis of familial adenomatous polyposis and sporadic ampullary adenomas in an international multicenter cohort.
- Author
-
Singh, Achintya D., Burke, Carol A., Draganov, Peter V., Bapaye, Jay, Nishimura, Makoto, Ngamruengphong, Saowanee, Kushnir, Vladimir, Sharma, Neil, Kaul, Vivek, Singh, Aparajita, Bapaye, Amol, Banerjee, Debdeep, Bayudan, Alexis, De Leon, Mariajose Rojas, Singh, Ritu R., Mony, Shruti, Gandhi, Ashish, Hollander, Thomas, Bittner, Krystle, and Beauvais, Jacques
- Subjects
- *
ADENOMATOUS polyposis coli , *ADENOMATOUS polyps , *ADENOMA , *BILE ducts , *COMPARATIVE studies ,BILIARY tract cancer - Abstract
Objectives: Endoscopic papillectomy (EP) is a minimally invasive therapy for the management of ampullary adenomas (AA). We conducted this multicenter study to assess the incidence of and factors related to the recurrence of AA after EP in patients with familial adenomatous polyposis (FAP) compared to sporadic AA. Methods: We included patients who underwent EP for AA at 10 tertiary hospitals. Adenomatous tissue at the resection site at the time of surveillance endoscopies was considered recurrent disease. Results: In all, 257 patients, 100 (38.9%) with FAP and 157 (61%) patients with sporadic AA, were included. Over a median of 31 (range, 11–61) months, recurrence occurred in 48/100 (48%) of patients with FAP and 58/157 (36.9%) with sporadic AA (P = 0.07). Two (2%) FAP patients and 10 (6.3%) patients with sporadic AA underwent surgery for recurrence. On multivariable regression analysis, the recurrence in FAP was higher than in sporadic patients after the first year of follow‐up. AA size (hazard ratio [HR] 1.03, 95% confidence interval [CI] 1.001, 1.056), periampullary extension (HR 2.5, 95% CI 1.5, 4.01), and biliary duct dilation (HR 2.04, 95% CI 1.2, 3.4) increased the risk, while en bloc resection (HR 0.6, 95% CI 0.41, 0.9) decreased the risk of recurrence. Conclusion: Recurrence rates are high after EP. Most recurrences in sporadic patients occur within the first year of follow‐up, but after the first year of follow‐up in patients with FAP. Recurrences are higher with larger adenomas, biliary duct dilation, and periampullary extensions, and may be mitigated by en bloc resection. These factors should be considered in decision‐making with the patients. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
41. Sonic hedgehog hepatocellular adenoma: magnetic resonance imaging features and correlation with histology.
- Author
-
Ducatel, Arnaud, Trillaud, Hervé, Reizine, Edouard, Vilgrain, Valérie, Sempoux, Christine, Schmidt-Kobbe, Sabine, Gouw, Annette S. H., de Haas, Robbert J, Julien, Céline, Paradis, Valérie, Blanc, Jean-Frédéric, Chiche, Laurence, Balabaud, Charles, Bioulac-Sage, Paulette, and Frulio, Nora
- Subjects
- *
MAGNETIC resonance imaging , *ADENOMA , *CYCLOOXYGENASES , *IMAGE analysis , *HEDGEHOG signaling proteins , *ADENOMATOUS polyps - Abstract
Objectives: Sonic hedgehog hepatocellular adenoma (shHCA) is a new hepatocellular adenoma (HCA) subgroup characterized by high risk of hemorrhage. ShHCA account for below 10% of all HCA cases and are often associated with female gender, obesity, and non-alcoholic steatohepatitis. No specific MRI characteristics have been described to date. The objective of this study was to assess the value of using MRI to identify shHCA, and correlate MRI findings with histology. Methods: We retrospectively collected MRI scans of 29 patients with shHCA from our center and from different liver referral centers to include 35 lesions. Diagnosis of shHCA was assessed by immunohistochemical overexpression of argininosuccinate synthase 1 or prostaglandin D2 synthase, then confirmed by molecular analysis of sonic hedgehog pathway activation and/or by proteomic analysis. Results: In 46% (n = 16/35) of shHCA cases, we detected intralesional fluid-filled cavities defined on MR images as fluid-like foci markedly hyperintense on T2-weighted sequences, and hypointense on T1-weighted sequences, with or without delayed enhancement. Pathologically, these cavities were observed in 54% of cases as vacuoles filled with blood at different stages of degradation. Hemorrhage and/or necrosis were detected among 71% of cases by MRI analysis (n = 25/35) versus 82% pathologically. Seventeen percent of shHCA cases (n = 6/35) were completely homogeneous via MRI and pathological analysis. No MRI criteria was found in favor of focal nodular hyperplasia, HNF1A-mutated HCA, or typical inflammatory HCA. Conclusion: We reveal the presence of intralesional fluid-filled cavities among 46% of our shHCA cases that represent a new MRI finding possibly helpful for shHCA diagnosis. Clinical relevance statement: This multicenter study is the first clinical study about the radiological aspect of this new hepatocellular adenoma subgroup. This highlights a strong correlation between MRI and histological analysis, with a specific pattern emerging for diagnosis. Key Points: • Sonic hedgehog hepatocellular adenoma is a new hepatocellular adenoma subgroup associated with high risk of hemorrhage, but imaging features of this subgroup remain unknown. • Analysis of MR images and correlation with pathology revealed intralesional fluid-filled cavities and necrotic-hemorrhagic changes. • Intralesional fluid-filled cavities have not yet been described in other adenoma subtypes and represent a new MRI finding for sonic hedgehog hepatocellular adenoma. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
42. Oral octreotide capsules for acromegaly treatment: application of clinical trial insights to real-world use.
- Author
-
Fleseriu, Maria, Nachtigall, Lisa B., Samson, Susan L., and Melmed, Shlomo
- Subjects
ACROMEGALY ,SOMATOSTATIN receptors ,ADVERSE health care events ,CLINICAL medicine ,CLINICAL trials ,ADENOMATOUS polyps - Abstract
Acromegaly is a rare endocrine disorder usually caused by a benign growth hormone‒secreting pituitary adenoma. Surgical adenoma resection is typically the first line of treatment, and medical therapy is used for patients with persistent disease following surgery, for adenoma recurrence, or for patients ineligible for, or declining, surgery. Approved somatostatin receptor ligands (SRLs) have been limited to injectable options, until recently. Oral octreotide capsules (OOC) are the first approved oral SRL for patients with acromegaly. We review published reports and provide case study examples demonstrating practical considerations on the use of OOC. Using two hypothetical case scenarios, we discuss current treatment patterns, breakthrough symptoms and quality of life (QoL), efficacy of SRLs, OOC dose titration, evaluation of OOC treatment response, and incidence and management of adverse events. OOC are an option for patients with acromegaly including those who experience breakthrough symptoms, who have preference for oral therapies, or other reasons for declining injectable SRLs. OOC have been associated with improved patient-reported QoL measures compared with those reported for lanreotide and octreotide. Continued real-world experience will determine whether OOC, alone or in combination with other therapies, provides further advantages over current injectable acromegaly treatments. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
43. Emerging and under-recognised patterns of colorectal carcinoma morphologies: a comprehensive review.
- Author
-
Yuho Ono and Yilmaz, Osman
- Subjects
ADENOMATOUS polyps ,BREAST ,COLORECTAL cancer ,TRANSITIONAL cell carcinoma ,SMALL cell carcinoma ,RECTAL diseases ,MORPHOLOGY - Published
- 2024
- Full Text
- View/download PDF
44. COLO-DETECT: Can an Artificial Intelligence Device Increase Detection of Polyps During Colonoscopy?
- Author
-
North Wales Organisation for Randomised Trials in Health, Newcastle University, and Medtronic
- Published
- 2023
45. Endoscopic Size Assessment of Advanced Adenomatous Polyps
- Published
- 2023
46. Epithelial misplacement in Peutz–Jeghers polyps—the efficacy of the distribution of immunohistochemical markers in its diagnosis.
- Author
-
Shepherd, Neil A, Wong, Newton A C S, and Sheahan, Kieran
- Subjects
- *
INTESTINAL polyps , *PEUTZ-Jeghers syndrome , *GASTROINTESTINAL system , *DIAGNOSTIC immunohistochemistry , *INTESTINAL mucosa , *ADENOMATOUS polyps - Abstract
This article discusses the diagnostic difficulties associated with epithelial misplacement in Peutz-Jeghers polyps, a rare autosomal dominant gastrointestinal polyposis syndrome. The polyps are characterized by well-organized arborising muscular fibers lined by normal or hyperplastic mucosa. Epithelial misplacement, particularly in the small intestine, can mimic well-differentiated adenocarcinoma, leading to misdiagnosis. The article explores the use of immunohistochemical markers in differentiating non-neoplastic epithelium from neoplastic epithelium and emphasizes the importance of accurate diagnosis to prevent over-treatment. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
47. Imaging of colorectal adenomas with pseudoinvasion and malignant polyps using two-photon excitation microscopy.
- Author
-
Florea, Maria-Alexandra, Eftimie, Lucian George, Glogojeanu, Remus Relu, Hristu, Radu, Stanciu, George A., and Costache, Mariana
- Subjects
POLYPS ,HEMATOXYLIN & eosin staining ,MICROSCOPY ,ADENOMA ,ADENOMATOUS polyps ,NASAL polyps ,IMAGE analysis - Abstract
Introduction: Although the incidence and mortality rates of colorectal cancer exhibit significant variability, it remains one of the most prevalent cancers worldwide. Endeavors to prevent colorectal cancer development focus on detecting precursor lesions during colonoscopy. The diagnosis of endoscopically resected polyps relies on hematoxylin and eosin staining examination. For challenging cases like adenomatous polyps with epithelial misplacement, additional diagnostic methods could prove beneficial. Methods: This paper aims to underscore stromal changes observed in malignant polyps and polyps with pseudoinvasion, leveraging two-photon excitation microscopy (TPEM), a technique extensively employed in the medical field in recent years. Results and discussions: Both the subjective and quantitative analysis of TPEM images revealed distinct distributions and densities of collagen at the invasion front in malignant polyps compared to areas of pseudoinvasion. TPEM holds potential in discerning true invasion in malignant polyps from pseudoinvasion, offering enhanced visualization of local stromal changes. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
48. Unveiling the Significance of NCAP Family Genes in Adrenocortical Carcinoma and Adenoma Pathogenesis: A Molecular Bioinformatics Exploration.
- Author
-
Arastonejad, Mahshid, Arab, Daniyal, Fatemi, Somayeh, and Golshanrad, Pezhman
- Subjects
- *
GENE families , *ADENOMA , *CHROMOSOME structure , *GENE expression , *ADRENAL cortex , *ADENOMATOUS polyps - Abstract
Objectives: Adrenocortical carcinoma (ACC), a rare and aggressive adrenal cortex cancer, poses significant challenges due to high mortality, poor prognosis, and early post-surgery recurrence. Variability in survival across ACC stages emphasizes the need to uncover its molecular underpinnings. Adrenocortical adenoma, a benign tumor, adds to diagnostic challenges, highlighting the necessity for molecular insights. The Non-SMC Associated Condensin Complex (NCAP) gene family, recognized for roles in chromosomal structure and cell cycle control. This study focuses on evaluating NCAP gene functions and importance in ACC through gene expression profiling to identify diagnostic and therapeutic targets. Methods: Microarray datasets from ACC patients, obtained from the Gene Expression Omnibus database, were normalized to eliminate batch effects. Differential expression analysis of NCAP family genes, facilitated by the GEPIA2 database, included survival and pathological stage evaluations. A Protein-Protein Interaction network was constructed using GeneMANIA, and additional insights were gained through Gene Ontology enrichment analysis, correlation analysis, and ROC curve analysis. Results: ACC samples exhibited elevated levels of NCAPG, NCAPG2, and NCAPH compared to normal and adenoma samples. Increased expression of these genes correlated with poor overall survival, particularly in advanced disease stages. The Protein-Protein Interaction network highlighted interactions with related proteins, and Gene Ontology enrichment analysis demonstrated their involvement in chromosomal structure and control. Differentially expressed NCAP genes showed positive associations, and ROC curve analysis indicated their high discriminatory power in identifying ACC from adenoma and normal samples. Conclusion: The study emphasizes the potential importance of NCAPG, NCAPG2, and NCAPH in ACC, suggesting roles in tumor aggressiveness and diagnostic relevance. These genes could serve as therapeutic targets and markers for ACC, but further exploration into their molecular activities and validation studies is imperative to fully harness their diagnostic and therapeutic potential, advancing precision medicine approaches against this rare but lethal malignancy. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
49. Decoding immune-related gene-signatures in colorectal neoplasia.
- Author
-
Omran, Thura Akrem, Tunsjø, Hege Smith, Jahanlu, David, Brackmann, Stephan Andreas, Bemanian, Vahid, and Sæther, Per Christian
- Abstract
Background: Colorectal cancer (CRC) is a significant health issue, with notable incidence rates in Norway. The immune response plays a dual role in CRC, offering both protective effects and promoting tumor growth. This research aims to provide a detailed screening of immune-related genes and identify specific genes in CRC and adenomatous polyps within the Norwegian population, potentially serving as detection biomarkers. Methods: The study involved 69 patients (228 biopsies) undergoing colonoscopy, divided into CRC, adenomatous polyps, and control groups. We examined the expression of 579 immune genes through nCounter analysis emphasizing differential expression in tumor versus adjacent non-tumorous tissue and performed quantitative reverse transcription polymerase chain reaction (RT-qPCR) across patient categories. Results: Key findings include the elevated expression of CXCL1, CXCL2, IL1B, IL6, CXCL8 (IL8), PTGS2, and SPP1 in CRC tissues. Additionally, CXCL1, CXCL2, IL6, CXCL8, and PTGS2 showed significant expression changes in adenomatous polyps, suggesting their early involvement in carcinogenesis. Conclusions: This study uncovers a distinctive immunological signature in colorectal neoplasia among Norwegians, highlighting CXCL1, CXCL2, IL1B, IL6, CXCL8, PTGS2, and SPP1 as potential CRC biomarkers. These findings warrant further research to confirm their role and explore their utility in non-invasive screening strategies. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
50. Colorectal Polyp Detection Model by Using Super-Resolution Reconstruction and YOLO.
- Author
-
Wang, Shaofang, Xie, Jun, Cui, Yanrong, and Chen, Zhongju
- Subjects
COLON polyps ,DEEP learning ,FEATURE extraction ,ADENOMATOUS polyps ,COLORECTAL cancer ,POLYPS - Abstract
Colorectal cancer (CRC) is the second leading cause of cancer-related deaths worldwide. Colonoscopy is the primary method to prevent CRC. However, traditional polyp detection methods face problems such as low image resolution and the possibility of missing polyps. In recent years, deep learning techniques have been extensively employed in the detection of colorectal polyps. However, these algorithms have not yet addressed the issue of detection in low-resolution images. In this study, we propose a novel YOLO-SRPD model by integrating SRGAN and YOLO to address the issue of low-resolution colonoscopy images. Firstly, the SRGAN with integrated ACmix is used to convert low-resolution images to high-resolution images. The generated high-resolution images are then used as the training set for polyp detection. Then, the C3_Res2Net is integrated into the YOLOv5 backbone to enhance multiscale feature extraction. Finally, CBAM modules are added before the prediction head to enhance attention to polyp information. The experimental results indicate that YOLO-SRPD achieves a mean average precision (mAP) of 94.2% and a precision of 95.2%. Compared to the original model (YOLOv5), the average accuracy increased by 1.8% and the recall rate increased by 5.6%. These experimental results confirm that YOLO-SRPD can address the low-resolution problem during colorectal polyp detection and exhibit exceptional robustness. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.